Thrivent Financial for Lutherans
RXST icon

Thrivent Financial for Lutherans’s RxSight RXST Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-312,220
Closed -$4.06M – 2574
2025
Q2 		$4.06M Sell
312,220
-139,382
-31% -$2.1M 0.01% 915
2025
Q1 		$11.4M Buy
451,602
+98,976
+28% +$2.94M 0.03% 568
2024
Q4 		$12.1M Buy
352,626
+122,989
+54% +$5.55M 0.02% 600
2024
Q3 		$11.3M Buy
+229,637
New +$11.8M 0.02% 638

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thrivent Financial for Lutherans's RXST Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of RxSight (RXST) in Q3 2025, closing a stake of 312,220 shares — an estimated $4.06M sold.

Thrivent Financial for Lutherans first reported a position in RXST in Q3 2024 and held it in 4 quarters. The position peaked at $12.1M in Q4 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 312,220 RxSight shares in Q3 2025, an estimated $4.06M.
  • Thrivent Financial for Lutherans first reported a position in RxSight in Q3 2024 and held it in 4 quarters.
  • Thrivent Financial for Lutherans's RxSight position peaked at $12.1M in Q4 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.